Researchers Develop Model to Detect & Combat Lung Cancer Recurrence
Researchers found a process to study the actions of circulating tumor cells responsible for cancer recurrence of non-small cell lung cancer.
Read MorePosted by Andy Lundin | Apr 8, 2022 | Lung Cancer |
Researchers found a process to study the actions of circulating tumor cells responsible for cancer recurrence of non-small cell lung cancer.
Read MorePosted by Andy Lundin | Jan 10, 2022 | Lung Cancer |
A blood test in tandem with reviewing an individual’s smoking history can more accurately determine if they may benefit from lung cancer screening.
Read MorePosted by Andy Lundin | Dec 15, 2021 | Clinical Chemistry, Lung Cancer |
A study shows proof-of-concept of using a drop of blood to reveal lung cancer, which may help diagnose early-stage lung cancer in asymptomatic patients.
Read MorePosted by Andy Lundin | Dec 10, 2021 | Lung Cancer |
Thermo Fisher’s companion diagnostic test to identify targeted therapies for non-small cell lung cancer patients was granted premarket approval by the FDA.
Read MorePosted by Andy Lundin | Dec 6, 2021 | Lung Cancer |
Biocept’s liquid biopsy-based Target Selector NGS Lung Panel test aids genomic profiling in patients with advanced non-small cell lung cancer (NSCLC).
Read More